Who is sponsoring NCT06137456?

NCT06137456 is sponsored by Ankara City Hospital Bilkent.

What drugs are being tested in NCT06137456?

Interventions in NCT06137456: Exoskeletal robotic therapy for walking., Conventional exercise therapy.

What condition does NCT06137456 study?

NCT06137456 studies Spinal Cord Injuries, Walking, Difficulty.

Is NCT06137456 still recruiting?

NCT06137456 is currently completed. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT06137456

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

First Report of a New Exoskeleton in Incomplete Spinal Cord Injury

Completed NA Last updated 18 November 2023

What this trial tests

NA trial testing Exoskeletal robotic therapy for walking. in Spinal Cord Injuries in 14 participants. Completed in 1 November 2023.

Timeline

1 January 2022

Primary endpoint
1 November 2023

1 November 2023

Quick facts

Lead sponsor	Ankara City Hospital Bilkent
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	1 January 2022
Primary completion	1 November 2023
Estimated completion	1 November 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Exoskeletal robotic therapy for walking.
Conventional exercise therapy

Conditions studied

Spinal Cord Injuries — all drugs for Spinal Cord Injuries →
Walking, Difficulty — all drugs for Walking, Difficulty →

Sponsor

Ankara City Hospital Bilkent

Who can join

18 and older, any sex, with Spinal Cord Injuries or Walking, Difficulty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the effects of exoskeletal robotic therapy and conventional exercise therapy in incomplete spinal cord injury (SCI). The main questions it aims to answer are: * Is exoskeletal robotic therapy effective in improving functional ambulation in SCI? * Is exoskeletal robotic therapy effective in enhancing Activities of Daily Living in SCI? Participants treated with either: * Exoskeletal robotic therapy along with conventional exercise therapy, or * Only conventional exercise therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

First report of a new exoskeleton in incomplete spinal cord injury: FreeGait<sup>®</sup>.
Şipal MS, Yaşar E, Özişler Z, Adıgüzel E, et al · · 2026 · PMID 39576286 · DOI 10.1080/10790268.2024.2426314

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
NCT07210411 — Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury · NA · recruiting
NCT07488793 — Remote Ischemic Conditioning for PwSCI · NA · recruiting
NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06137456 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06137456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing